Synthesis and Antibacterial Activity of Pregnenolone-Vitamin B1 Conjugate
DOI:
https://doi.org/10.29356/jmcs.v52i2.1059Keywords:
pregnenolone, hemisuccinate-pregnenolone-vitamine B1, quaternary amineAbstract
In this work was synthesized a pregnenolone derivative; the route involved preparation of pregnenolone hemisuccinate (2) by esterification of pregnenolone (1) with succinic anhydride followed by formation of the hemisuccinate of pregnenolone-vitamin B1 conjugate (3). The antibacterial activity of compound 3, as well as 2 and vitamin B1, was evaluated in vitro on S. aureus, K. pneumoniae and E. coli using dilution method and the minimum inhibitory concentration (MIC). The structure of 3 was confirmed by spectroscopy and spectrometry data. The 1H NMR spectrum showed, up field shifts at 2.52 and 2.58 ppm for methyls present in the heterocyles rings; at 2.90 and 3.77 methylenes of the hydroxietilen moiety bonded to thiazol ring, in addition the hydrogens of the methylene between the pyrimidine and thiazol ring appears at 4.39 ppm. At down field there are two chemical shifts (7.54, 8.33) corresponding to protons in the heterocyles. The results of the biological activity indicate that the bacterial growth of the microorganisms studied was inhibited by 3, and 2 in a manner dose-dependent, but not by vitamin B1. These data suggest that quaternary amine group involved in the HPVB1 conjugate requires the hydrophobic region of the steroid in order to interact with some components of bacterial cell, disturbing the bacterial growth and to cause cell death.
Downloads
References
2. Crossley, K.B.; Peterson, P. Clin. Infec. Dis. 1996, 22, 209-215.
3. Norman, D.C. Clin. Geriatrics. Suppl. 1996, 1, 3-5.
4. Chambers, H.F. Emerg. Infec. Dis. 2001, 7, 178-182.
5. Podschun, R; Ullmann, U. Clin. Microbiol. Rev. 1998, 11, 589-603.
6. Lautenbach, E.; Patel, J.B.; Bilker, W.B.; Edelstein, P.H.; Fishman, N. Clin. Infec. Dis. 2001, 32, 1162-1171.
7. Rothstein, D. M.; Hartman, A.; Cynamon, M.; Eisenstein, B. Expert Opin. Invest. Drugs. 2003, 12, 255-271.
8. Wilson, W.R.; Karchmer, A.W.; Dajani, A. J. Am. Med. Assoc. 1995, 274, 1706-13.
9. Yoo, B.; Triller, D.; Yong, C.; Lodise, T. Ann. Pharmacoth. 2004, 38, 1226-1235.
10. Killgore, M.; March, K.; Guglielmo, B. Ann. Pharmacoth. 2004, 38, 1148-1152.
11. Hackbarth, C.J.; Chambers, H. Antimicrob. Agents & Chem. 1989, 33, 995–9.
12. Maguire, G.P.; Arthur, A.D.; Boustead, P.J.; Dwyer, B.; Currie, B. J. Hospital. Infect. 1998, 38, 273–81.
13. Peschel, A. Trends Microbiol. 2002, 10, 179-186.
14. Yeaman, M.; Younth, N. Pharmacol. Rev. 2005, 55, 27-55.
15. Ayliffe, G.A. Clin. Infect. Dis. 1997, 24, S74-79.
16. Merlino, J.; Watson, J.; Rose, B.; Beard, M.; Gottlieb, T.; Bradbury, R.; Harbour, C. J. Antimicrob. Chem. 2002, 49, 793-801.
17. Podschun, R.; Ullmann, U. Clin. Microb. Rev. 1998, 11, 589-603.
18. Prats, G.; Mireñis, B.; Miró, E.; Navarro F. Emerg. Infect. Dis. 2003, 9, 1273-1279.
19. Gordon, E.; Barrett, R.; Dower, J. J. Med. Chem. 1994, 37, 1385-1401.
20. Schwab, U.; Gilligan, P.; Jaynes, J.; Henke, D. Antimicrob. Agents. Chemother. 1999, 43, 1435-1440.
21. Patch, J. A.; Barron, A. J. Am. Chem. Soc. 2003, 125, 12092-12093.
22. Li, C.; Peters, A.; Meredith, E.; Allman, G.; Savage, P. J. Am. Chem. Soc. 1998, 120, 2961-2962.
23. Ding, B.; Yin, N.; Cardenas, G.J.; Evanson, R.; Orsak, T.; Fan, M.; Turin, G.; Savage, P. J. Am. Chem. Soc. 2004, 126, 13642-13648.
24. Kikuchi, K.; Bernard, E.M.; Sadownik, A.; Regen, S.; Armstrong, D. Antimicrob. Agents Chemother. 1997, 41, 1433-1438.
25. Ding, B.; Guan, Q.; Walsh, J.; Boswell, J.; Winter, T.; Winter, E.; Boyd, S.; Li, C.; Savage, P. J. Med. Chem. 2002, 45, 663-669.
26. Ding, B.; Taotofa, U.; Orsak, T.; Chadwell, M.; Savage, P. Organic letters. 2004, 6, 3433-3436.
27. Chiong, R.; Betancourt, A. Instituto Nacional de Higiene, Epidemiología y Microbiología, La Habana, Cuba. 1985, 24-30.
28. Figueroa, V. L.; Díaz, C.F.; Tolosa, L.; Maldonado, G.; Ceballos R.G. J. Mexican. Chem. Soc. 2006, 50, 42-45.
29. Rannard, S.P.; Davis, N.J. The Selective Reaction of Primary Amines with Carbonyl Imidazole Containing Compounds: Selective Amide and Carbamate Synthesis. Org. Lett. 2000, 2, 2117-2120.
30. Bode, J.W.; Sohn, S. N-Heterocyclic Carbene-Catalyzed Redox Amidations of a-Functionalized Aldehydes with Amines. J. Am. Chem. Soc. 2007, 129, 13798-13799.
31. Hauser, R.S.; Hoffenberg, D. Convertion of nitriles to amides and acids by means of boron fluoride. J. Org. Chem.; 1955, 20, 1448-1453.
32. Medvedeva, A.; Andreev, M.; Safronova, L.; Sarapulova, G.; Afonin, Arkivoc. 2001, ix, 143-149.
33. Levin, D. Org. Process Res. Dev. 1997, 1, 182-182.
34. DeSilva, N. S. Am. J. Respir. Cell Mol. Biol. 2003, 29, 757-770
35. Thorsteinsson, T.; Masson, M.; Kristinsson, K.; Hjalmarsdottir, M.; Hilmarsson, H.; Loftsson T. J. Med. Chem. 2003, 46, 4173-4181.
36. Fisher, W. Handbook of lipid research: glycolipids, phospholipids, and sulfoglycolipids. Kates (Eds.), Plenum Publishing Corp. NY, New York. 1990, 123-234.
37. Cheng, Y.; Ho, D.M.; Gottlieb, C.R.; Kaen, D. J. Am. Chem. Soc. 1992, 114, 7319-7320.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
